SUBSCRIBE
SUBSCRIBE
News   Deals

AstraZeneca PLC (JOBS) CEO Says Firm Mulls Branded Generic Buy in Emerging Markets

September 24, 2008 | 
1 min read
LONDON (MarketWatch) -- AstraZeneca PLC will consider acquiring branded generic drugs in emerging countries as it boosts its business outside the U.S. and Europe, Chief Executive David Brennan said Tuesday.
Mergers & acquisitions Europe
AstraZeneca
MORE ON THIS TOPIC
Upward arrow on the background of the flag of China. Paper plane. Economic recovery. Copy space. Business. Background.
China
Deerfield bets up to $1.6B to snag autoimmune asset in China for Boulevard
June 30, 2026
 · 
1 min read
 · 
Annalee Armstrong
Solution Concept with Handshake on Chalkboard Background
Mergers & acquisitions
Zymeworks adds lung disease drug, royalty deals in nearly $1B pick up of Theravance
June 29, 2026
 · 
2 min read
 · 
Annalee Armstrong
Business handshake trendy halftone art collage banner template. Partnership concept, successful agreement, closing a deal, securing a contract. Modern retro cut out vector illustration
Mergers & acquisitions
Ipsen makes up to $1.75B blood cancer bet with Kartos buyout
June 29, 2026
 · 
2 min read
 · 
Tristan Manalac
Big fish eats small, takeover of the company. Art collage.
M&A
Merck KGaA inks $11B Bio-Techne buyout to expand into cell therapy production
June 26, 2026
 · 
2 min read
 · 
Nick Paul Taylor